Rapid and sustained response to tralokinumab in a patient with severe bullous pemphigoid and end-stage kidney disease
Roberto Maglie, Maria Efenesia Baffa, Stefano Senatore, Carlo Pipitò, Marzia Caproni, Farzan Solimani, Emiliano Antiga
Abstract
Tralokinumab as a novel therapeutic approach for bullous pemphigoid.
Topics & Concepts
Bullous pemphigoidMedicinePemphigoidEnd-stage kidney diseaseDermatologyStage (stratigraphy)Kidney diseaseInternal medicineImmunologyAntibodyBiologyPaleontologyAutoimmune Bullous Skin DiseasesDermatology and Skin DiseasesUrticaria and Related Conditions